Salarius Inventory from 2010 to 2024

SLRX Stock  USD 1.37  0.09  6.16%   
Salarius Pharmaceuticals Inventory yearly trend continues to be fairly stable with very little volatility. Inventory is likely to outpace its year average in 2024. During the period from 2010 to 2024, Salarius Pharmaceuticals Inventory regression line of annual values had r-squared of  0.70 and arithmetic mean of (150,026). View All Fundamentals
 
Inventory  
First Reported
2016-03-31
Previous Quarter
380.1 K
Current Value
110.4 K
Quarterly Volatility
503.1 K
 
Yuan Drop
 
Covid
Check Salarius Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Salarius Pharmaceuticals' main balance sheet or income statement drivers, such as Interest Income of 441.7 K, Depreciation And Amortization of 9.55 or Interest Expense of 281.6 K, as well as many indicators such as Price To Sales Ratio of 97.37, Dividend Yield of 0.0011 or PTB Ratio of 3.05. Salarius financial statements analysis is a perfect complement when working with Salarius Pharmaceuticals Valuation or Volatility modules.
  
Check out the analysis of Salarius Pharmaceuticals Correlation against competitors.
For more information on how to buy Salarius Stock please use our How to Invest in Salarius Pharmaceuticals guide.

Latest Salarius Pharmaceuticals' Inventory Growth Pattern

Below is the plot of the Inventory of Salarius Pharmaceuticals over the last few years. It is Salarius Pharmaceuticals' Inventory historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Salarius Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.
Inventory10 Years Trend
Slightly volatile
   Inventory   
       Timeline  

Salarius Inventory Regression Statistics

Arithmetic Mean(150,026)
Geometric Mean0.00
Coefficient Of Variation(577.55)
Mean Deviation726,305
Median432,000
Standard Deviation866,482
Sample Variance750.8B
Range2.1M
R-Value(0.84)
Mean Square Error243.4B
R-Squared0.70
Significance0.0001
Slope(161,982)
Total Sum of Squares10.5T

Salarius Inventory History

2024-1.4 M
2023-1.4 M
2021-1.6 M
2019null
2018187 K
2017432 K

Other Fundumenentals of Salarius Pharmaceuticals

Salarius Pharmaceuticals Inventory component correlations

About Salarius Pharmaceuticals Financial Statements

Salarius Pharmaceuticals investors use historical fundamental indicators, such as Salarius Pharmaceuticals' Inventory, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Salarius Pharmaceuticals. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Inventory-1.4 M-1.4 M
Change To Inventory(1.15)(1.09)
Days Of Inventory On Hand-101.2 K-96.2 K
Days Of Inventory Outstanding-101.2 K-96.2 K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Salarius Stock Analysis

When running Salarius Pharmaceuticals' price analysis, check to measure Salarius Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Salarius Pharmaceuticals is operating at the current time. Most of Salarius Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Salarius Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Salarius Pharmaceuticals' price. Additionally, you may evaluate how the addition of Salarius Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.